330794-02-0 Usage
Uses
Used in Pharmaceutical Industry:
1-Bromo-2-fluoro-5-methoxy-4-nitrobenzene is used as a building block for the synthesis of pharmaceuticals, contributing to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 1-Bromo-2-fluoro-5-methoxy-4-nitrobenzene is utilized as a precursor in the synthesis of agrochemicals, such as pesticides and herbicides, to enhance crop protection and yield.
Used in Research and Development:
1-Bromo-2-fluoro-5-methoxy-4-nitrobenzene is used as a reagent or intermediate in various chemical reactions, facilitating the advancement of scientific research and the development of novel compounds.
Used in Materials Science:
1-BroMo-2-fluoro-5-Methoxy-4-nitrobenzene has potential applications in the field of materials science, where it can be employed to create new materials with specific properties for various applications.
Used as a Precursor for Specialty Chemicals:
1-Bromo-2-fluoro-5-methoxy-4-nitrobenzene serves as a precursor for the preparation of specialty chemicals, which can be used in diverse industries, including coatings, dyes, and polymers.
It is crucial to handle and store 1-bromo-2-fluoro-5-methoxy-4-nitrobenzene with care due to its toxic and potentially harmful nature, ensuring safety in its applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 330794-02-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,0,7,9 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 330794-02:
(8*3)+(7*3)+(6*0)+(5*7)+(4*9)+(3*4)+(2*0)+(1*2)=130
130 % 10 = 0
So 330794-02-0 is a valid CAS Registry Number.
330794-02-0Relevant articles and documents
Pyrazolopyrimidines as therapeutic agents
-
, (2008/06/13)
The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.
Pyrazolopyrimidines as therapeutic agents
-
, (2008/06/13)
The present invention provides compounds of Formula I, including pharmaceutically acceptable salts and/or prodrugs thereof, where G, R2, and R3 are defined as described herein.
